4.5 Review

Adenosine-associated delivery systems

Journal

JOURNAL OF DRUG TARGETING
Volume 23, Issue 7-8, Pages 580-596

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.3109/1061186X.2015.1058803

Keywords

Adenosine; controlled drug delivery; controlled release; drug delivery; drug targeting; nanoparticles; targeted drug delivery

Funding

  1. National Science Foundation [EFRI-1240443]
  2. IMMODGEL [602694]
  3. National Institutes of Health [EB012597, AR057837, DE021468, HL099073, AI105024, AR063745]

Ask authors/readers for more resources

Adenosine is a naturally occurring purine nucleoside in every cell. Many critical treatments such as modulating irregular heartbeat (arrhythmias), regulation of central nervous system (CNS) activity and inhibiting seizural episodes can be carried out using adenosine. Despite the significant potential therapeutic impact of adenosine and its derivatives, the severe side effects caused by their systemic administration have significantly limited their clinical use. In addition, due to adenosine's extremely short half-life in human blood (<10 s), there is an unmet need for sustained delivery systems to enhance efficacy and reduce side effects. In this article, various adenosine delivery techniques, including encapsulation into biodegradable polymers, cell-based delivery, implantable biomaterials and mechanical-based delivery systems, are critically reviewed and the existing challenges are highlighted.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available